Initial efficacy and safety of RP1 + nivolumab in patients with anti-PD-1-failed melanoma from the ongoing phase 1/2 IGNYTE study.
Nivolumab;RP-1
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Initial efficacy and safety of RP1 + nivolumab in patients with anti-PD-1-failed melanoma from the ongoing phase 1/2 IGNYTE study. ### Output: Nivolumab;RP-1